Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: Discoloration
| Brand name | PANTOPRAZOLE SODIUM |
| Generic name | PANTOPRAZOLE |
| Active ingredient(s) | PANTOPRAZOLE SODIUM |
| Distributed by / for | Camber Pharmaceuticals Inc., Piscataway, NJ, 08854, By: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahabubnagar- 509 301, India |
| NDC | 31722-713-10 |
| Full product label | Pantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals Inc., Piscataway, NJ, 08854, By: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahabubnagar- 509 301, India NDC 31722-713-10 |
| Recalling firm | Hetero USA Inc |
| Distribution | Nationwide within the United States |
| Quantity | 2,352 bottles |
| Recall initiated | 2023-03-14 |
| Report date | 2023-04-19 |
| Recall completed | — |
| Recall number | D-0530-2023 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Piscataway NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗